Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Homo sapiens | vitamin D (1,25- dihydroxyvitamin D3) receptor | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Brugia malayi | steroid hormone receptor | vitamin D (1,25- dihydroxyvitamin D3) receptor | 427 aa | 416 aa | 24.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.1033 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0783 | 0.1661 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0403 | 0.3684 | 1 |
Leishmania major | dihydroorotate dehydrogenase | 0.1033 | 1 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0403 | 0.3684 | 0.3148 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1692 | 0.2171 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0783 | 0.1661 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0403 | 0.3684 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0114 | 0.0783 | 0.2125 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.1033 | 1 | 0.5 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0403 | 0.3684 | 1 |
Schistosoma mansoni | kinase | 0.0058 | 0.022 | 0.022 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0783 | 0.1661 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0403 | 0.3684 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0403 | 0.3684 | 1 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0403 | 0.3684 | 0.3684 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1033 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1692 | 0.1692 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0403 | 0.3684 | 0.4728 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.1033 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1692 | 0.1692 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0783 | 0.1661 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1033 | 1 | 1 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0403 | 0.3684 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0783 | 0.1661 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 0.0783 | 0.0783 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.1033 | 1 | 1 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0403 | 0.3684 | 0.4728 |
Echinococcus granulosus | geminin | 0.0205 | 0.1692 | 0.4591 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.1033 | 1 | 0.5 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1033 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0403 | 0.3684 | 1 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.1033 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.1033 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0783 | 0.1661 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0114 | 0.0783 | 0.2125 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.1033 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0403 | 0.3684 | 1 |
Giardia lamblia | Kinase, PLK | 0.0114 | 0.0783 | 0.5 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0403 | 0.3684 | 1 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.1033 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0783 | 0.1661 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0114 | 0.0783 | 0.1005 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0114 | 0.0783 | 0.0783 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0813 | 0.7792 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1033 | 1 | 1 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 0.0783 | 0.5 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 0.0783 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0033 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 2.9093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.9173 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.